Star Imaging and Path Lab Ltd

₹ 138 -6.57%

14 Nov - close price

About

Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.^[1]

Key Points

Business Profile^[1]
Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.

Website BSE

Market Cap ₹ 240 Cr.
Current Price ₹ 138
High / Low ₹ 152 / 123
Stock P/E 12.2
Book Value ₹ 61.4
Dividend Yield 0.00 %
ROCE 34.7 %
ROE 40.6 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company has a good return on equity (ROE) track record: 3 Years ROE 33.9%

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has high debtors of 222 days.
Working capital days have increased from 43.5 days to 121 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE SME IPO

Edit Columns

Loading peers table ...

Detailed Comparison with:

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2024	Sep 2025
	43	45
	31	28
Operating Profit	12	17
OPM %	27%	38%
	0	0
Interest	1	1
Depreciation	2	3
Profit before tax	8	14
Tax %	25%	26%
	6	10
EPS in Rs	41.40	5.77
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	69	58	79	84
	54	52	55	54
Operating Profit	15	6	23	29
OPM %	21%	10%	30%	35%
	0	0	1	0
Interest	2	2	3	3
Depreciation	4	3	5	5
Profit before tax	9	1	16	21
Tax %	33%	35%	23%	26%
	6	1	12	16
EPS in Rs	41.93	3.87	82.80	11.80
Dividend Payout %	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	7%
TTM:	6%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	36%
TTM:	37%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	34%
Last Year:	41%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	2	2	2	14	17
Reserves	17	17	30	34	89
	30	27	31	33	20
	10	16	20	18	23
Total Liabilities	58	61	82	98	150
	15	19	22	21	26
CWIP	0	0	0	0	0
Investments	0	0	0	0	0
	43	42	60	77	124
Total Assets	58	61	82	98	150

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	14	5	18	-6
	-4	-7	-7	-4
	-7	-5	2	-0
Net Cash Flow	3	-7	13	-10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	85	110	152	222
Inventory Days
Days Payable
Cash Conversion Cycle	85	110	152	222
Working Capital Days	6	-13	23	121
ROCE %		6%	34%	35%

Shareholding Pattern

Numbers in percentages

4 Recently

	Sep 2025
	71.92%
	1.37%
	9.33%
	17.38%
No. of Shareholders	779

	Sep 2025
	71.92%
	1.37%
	9.33%
	17.38%
No. of Shareholders	779

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

No data available.

DRHP